Dachaigh › Leukemia biphenotypic geur › New York

Sgrùdaidhean clionaigeach Leukemia biphenotypic geur ann an New York

Tha 11 sgrùdaidhean airson Leukemia biphenotypic geur a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Albany Medical Center, Albany
Roswell Park Cancer Institute, Buffalo
The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
agus 7 a bharrachd

A’ fastadhÌre 2

365 Days · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Montefiore Medical Center, New York

A’ fastadhÌre 1/2

30 Days · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT04065399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
agus 12 a bharrachd

A’ fastadhÌre 3

365 Days – 25 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Albany Medical Center, Albany
Maimonides Medical Center, Brooklyn
NYU Langone Hospital - Long Island, Mineola
agus 7 a bharrachd

A’ fastadhÌre 1/2

Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

New York Medical College, Valhalla

A’ fastadhÌre 1/2

Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Memorial Sloan- Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06177067

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Weill Cornell Medicine - New York Presbyterian Hospital, New York

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
agus 1 a bharrachd

A’ fastadhÌre 1/2

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT07356154

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 8 Faoi 2026 · NCT04872478

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital New York-Presbyterian, New York
Memorial Sloan Kettering Cancer Center, New York

A’ fastadhÌre 1

Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.